STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
STAT News · LC · trust 42/100
AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks
Read the original at STAT News →
Open in TruthVane →